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Introduction
Organic phosphorus compounds are of
considerable interest and importance by virture of their widespread use as insecticides;
their effectiveness in the treatment of myasthenia gravis, glaucoma, and abdominal
distention; and their potential application as
war gases. These compounds owe their
pharmacologic effect primarily, if not entirely, to their ability to inhibit the enzyme
cholinesterase with a resultant overstimulation of the parasympathetic nervous system
by the acetylcholine which accumulates.
Atropine has been the drug of choice for the
treatment of organophosphorus poisoning.
Submitted for publication Dec. 12, 1961.
From the Toxicology Section, Technology Branch,
Communicable Disease Center, Public Health
Service, U.S. Department of Health, Education,
and Welfare, Wenatchee, Wash. (Dr. Durham) and
Atlanta (Dr. Hayes).

This therapy produces relief of symptoms
based on blocking the action of excess acetylcholine.
More recently, a number of specific antidotes have been developed which act to repair
the basic biochemical lesion in organic phosphorus poisoning by freeing the cholinesterase from its combination with the inhibitor.
In the present paper, some of the pertinent
background material relative to' organic phosphorus poisoning will be reviewed, and the
properties and usage of these specific antidotes will be discussed in some detail. Emphasis will be given to those aspects of
symptomatology and treatment which might
be of most value to the physician faced with
a presumptive case of poisoning.
Nature and Physiologic Function
of Cholinesterase
There are 2 general types of cholinesterase
present in the animal organism.9 These are:
( 1) the true, specific enzyme, acetylcholinesterase, which has an almost specific affinity
for the naturally occurring substrate acetylcholine, although it will hydrolyze several
synthetic esters; and (2) the nonspecific
enzyme, pseudocholinesterase, which has the
ability to hydrolyze quite a wide range of
naturally occurring and synthetic esters in
addition to acetylcholine. Acetylcholinesterase occurs in the nervous system, where it is
of great functional importance; in muscles;
and in glands; and it also occurs incidentally
in erythrocytes. The pseudoenzyme is found
in the blood plasma and in various tissues,
including the central nervous system.

.
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In addition to location and substrate specificity, there are other differences between
true and pseudocholinesterases. The latter
functions well in the presence of an excess
of substrate, while the former is inhibited
under this condition. A number of inhibitors
show considerable specificity for 8ne type of
enzyme. For example, diisopropyl fluorophosphate (DFP) in low concentrations is almost
completely specific for pseudocholinesterase. 73
It has been suggested that certain direct
effects of the anticholinesterase organic
phosphorus compounds do not depend on
inhibition of cholinesterase. w5 Von Kaulla
and Holmes 142 have reported that patients
poisoned by organic phosphorus compounds
show abnormalities in the blood-clotting
mechanism, but the changes were in both
directions from normal and must be considered unconfirmed. Some of the compounds
do produce a delayed reaction similar to
"J ake-Ieg paralysis," 11,41,94 but the clinical
picture is quite distinct from that of ordinary
poisoning. Although any statement about the
relationship between cholinesterase inhibition
and the classical picture of poisoning must be
qualified in terms of the rate of depression,
the degree of depression, and perhaps other
factors, the evidence for a lack of relationship is indefinite. On the contrary, the evidence for a lack of relationship between
cholinesterase inhibition and paralytic effect
is much more clear. In spite of these exceptions, it is true that the predominant pharmacologic effect of the organic phosphorus
compounds is inhibition of the enzyme acetylcholinesterase.
In order to have an understanding of the
action of acetylcholinesterase and of the
effect of its inhibition on the animal organism, it is first necessary to look at the physiologic action of acetylcholine. Acetylcholine is
the chemical mediator of the parasympathetic
nervous system and is necessary for transmission of the nervous impulse (1) from
preganglionic fibers to autonomic ganglia;
(2) from postganglionic, cholinergic nerves
to smooth and cardiac muscle and to secretory cells: (3) from motor nerves to striated
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muscle; and probably (4) from certain structures within the central nervous system.
Normally, in the presence of the usual concentration of cholinesterase, the acetylcholine
formed during the process of transmission
is hydrolyzed almost instantly so that the
synapse is again ready to transmit a physiologic impulse. A small abnormal accumulation of acetylcholine at the synapse or
myoneural junction produces an abnormal
increase in function (e.g., fasciculation of
muscle), while greater accumulation rapidly
produces a decrease in function (e.g., paralysis). A decrease in cholinesterase activity
is accompanied by an accumulation of acetylcholine. The symptoms caused by organic
phosphorus poisoning are, therefore, very
similar to those resulting from overstimulation of the parasympathetic nervous system.
Symptoms of Organic
Phosphorus Poisoning
Absorption of the organic phosphorus
anticholinesterases may occur through the
lungs, gastrointestinal tract, or skin. Absorption of these materials is more rapid and
more complete through the former 2 routes
than through the latter. Respiratory exposure
may be of predominant importance wherever
there is a sufficient concentration of vapor
or of aerosol fine enough to inhale. However,
in many agricultural and public health usages,
workers get contamination predominantly on
their skins. 13 ,3o,42 The oral route of 'exposure
occurs in accidental poisoning (particularly
of children), in murder, and in suicide. Ingestion has not been considered of importance in occupational exposurt; but a case
has been reported in which a parathion sprayman became severely poisoned, presumably
from eating a candy bar which he had been
carrying for 6 hours in an open outside
pocket of his work clothes. 120
Although many of the organic phosphorus
compounds have a high acute toxicity, agricultural residues of these materials on food
have not been a problem, due to their rapid
breakdown and the fact that they are not
stored in the animal body.40 Direct contamination of food by concentrated formulations
Vol. 5, July, 1962
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of these insecticides during shipment has
been the cause of several outbreaks of poisoning in other countries.
The symptom picture in organic phosphorus poisoning may vary in severity, in
rapidity of onset, in duration, and in range,
depending upon the route and the magnitude
of exposure. Minor exposure to a vapor or
aerosol of a direct inhibitor of cholinesterase
may produce local effects on the eye or respiratory system through local absorption
and without systemic effect. The optic effects
consist of miosis, a sensation of pressure in
or behind the eye, headache, and conjunctival
hyperemia. Unilateral manifestation of these
optic effects has been implicated in visual
difficulties experienced by pilots applying
these materials.140 The local effects on the
respiratory tract involve increased secretion,
a feeling of tightness in the chest, and
occasionally wheezing. Localized massive
dermal exposure can lead to muscular fasciculation and sweating confined to the area
of absorption.
Systemic effects may follow absorption by
any route. If there has been adequate exposure to a vapor or aerosol, the local respiratory effects already described will appear,
but they will be rapidly followed by more
severe optic and respiratory distress and
by systemic manifestations. Dixon 38 has
pointed out that too much reliance should
not be placed on miosis as a diagnostic sign,
since some poisoning cases, at least early in
their course, do not exhibit miosis, and a few
even have mydriasis.
In systemic poisoning, the muscarine-like
effects are usually first to appear. They include anorexia, nausea, sweating, epigastric
and substernal tightness (probably due to
cardiospasm), heartburn, belching, and tightness in the chest. The sequence of symptoms
varies somewhat with the route of exposure
-gastrointestinal effects usually being earliest after ingestion; sweating, and at times
muscular fasciculations, after dermal exposure; and respiratory effects after inhalation. More severe exposure by whatever
route produces abdominal cramps, increased
peristalsis, vomiting, diarrhea, salivation,
Durham-Hayes
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lacrimation, profuse sweating, pallor, and
dyspnea. In some subjects there is audible
wheezing. More severe signs and symptoms
include involuntary defecation and urination,
excessive bronchial secretions, and (according to some authors) pulmonary edema.
Nicotine-like effects appear usually after
the muscarine-like effects have reached moderate severity. These include muscle twitching, fasciculations, and cramps. At about the
same time, there appears increased fatigability and mild, generalized weakness which is
increased by exertion. Extensive exposure
produces severe weakness, including weakness of the muscles of respiration. There may
be a mild or moderate elevation of blood
pressure.
The central-nervous-system effects include
tension, anxiety, restlessness, giddiness, and
emotional lability. Late effects include insomnia, excessive dreaming, and occasionally
nightmares. Greater exposure produces headache, tremor, drowsiness, difficulty in concentration, slowness of recall, and confusion.
There may be withdrawal and depression.
In the absence of symptoms, there is no
change in the electroencephalogram {EEG).66
Mild symptoms are accompanied by a slight
diminution in potential, and moderate symptoms are accompanied by irregularity of
rhythm, variation and increase of potential,
and bursts of abnormal waves more or less
reminiscent of waves seen in epileptics. 107
Lethal or near-lethal doses produce ataxia,
slurring of words, multiple repetition of
the last syllable of words, coma, areflexia,
Cheyne-Stokes breathing, and finally, respiratory arrest.
The cause of death may usually be attributed to interference with respiration. 66
Animal experiments have proved that the
anticholinesterase organic phosphorus compounds interfere with respiration in at least
4 ways, including bronchoconstriction, excessive respiratory secretion, failure of the
muscles of respiration, and depression of the
respiratory center. Although the respiratory
center is at first stimulated by anoxia of
whatever cause, it is rapidly depressed by
continued anoxia. The severe bronchial con-
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striction seen in animals following exposure
to parathion or nerve gas has not been seen
in man. 66 The difference may depend on the
different amount of bronchial musculature
in different species.
The compounds also produce bradycardia
and various degrees of A-V block. If these
effects are prevented by atropine, and if the
animal is prevented from a respiratory death
by artificial respiration, it will eventually
succumb to a sufficient dose through dysfunction of the heart. This dysfunction will take
the form of ventricular fibrillation if atropine
should be administered in the presence of
severe anoxia. 1l;7 Even if atropine is given
correctly, bradycardia and perhaps impaired
contractility appear shortly before asystole
in the animal maintained by artificial respiration. 83 Unanesthetized dogs, unlike anesthetized ones, exposed to sarin by various
routes generally show bradycardia, increase
in pulse amplitude, decrease in oxygen tension, increase in carbon dioxide tension, and
fall in arterial blood pH before changes in
respiratory rate and volume are evident.l;8.5lJ
The local effects of organic phosphorus
exposure begin within a few minutes after
exposure and last for periods ranging from
several hours to a day, except that miosis may
last 2 to 5 days or occasionally longer. Moderate systemic effects begin within about half
an hour after respiratory exposure, threequarters of an hour after oral exposure, and
2 to 3 hours after dermal exposure. With
sufficient exposure, the onset of symptoms is
essentially instantaneous, with death in a few
minutes. Moderately severe symptoms may
not reach their maximum until 4 to 8 hours
after onset; they diminish over a period of
1 to 6 days. However, EEG changes may
persist for 11 to 18 days.66
Mechanism of Inhibition
of Cholinesterase
In recent years, much has been learned
about the molecular forces involved in the
interaction of acetylcholinesterase both with
its natural substrate and with organic phosphorus inhibitors.111 Wilson and Bergmann 153 have postulated that the surface of
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the enzyme protein contains 2 active centers,
an "anionic site" and a "cationic or esteratic
site." The former, by means of coulombic
forces, attracts the positively charged quaternary nitrogen atom of acetylcholine and
thereby fixes and orients the substrate in a
proper position so that the esteratic site can
exert its hydrolytic effect. The esteratic site
is thought to consist of a hydrogen-bonding
group which anchors the ester end of the
acetylcholine molecule. It has been suggested
that the ester-anchoring group may be the
iminazole ring of histidine and that any phosphoryl group which becomes attached here
is subsequently transferred to an adjacent
serine moiety of the enzyme molecule by a
N~O shift. It is thought that the effect of
change in pH on the hydrolytic activity of
this enzyme is mediated through changes in
ionization at these 2 sites.
In the following stage of the physiologic
reaction, the acetylcholine is split into choline
which is set free and the acetyl moiety which
remains affixed to the enzyme. However, the
acetylated enzyme is unstable and easily
breaks down to form active enzyme and
acetic acid.
The reaction between enzyme and organic
phosphorus inhibitor is thought to involve
only the esteratic site, except with the phosphorylcholines 57 that are used as laboratory
tools only and need not be discussed further.
This center is phosphorylated to form a complex which is, at least by contrast with the
acetylated enzyme, quite stable. The phosphorylation is thought to proceed in 2 stages,
as discussed in detail below under "Chemical
and Physiologic Properties of Oximes." The
stability of this phosphorylated enzyme accounts for the fact that organic phosphorus
compounds are inhibitors rather than substrates for cholinesterase. During this inhibition reaction, the anionic site remains
uninvolved.
Measurement of Cholinesterase
Activity and Its Relationship
to Symptomatology
Cholinesterase activity can be determined
by any of several methods based on: (l) diVol. 5, July, 1962
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rect or indirect measurement of the acetic
acid or other moiety released by hydrolysis
of acetylcholine or other esters, or (2) direct
measurement of acetylcholine remaining
after partial hydrolysis.
The electrometric method of Michel 107 together with a micromodification of this technique for use with capillary blood samples 104
is probably the most widely used method.
There are also available colorimetric,W6 titrimetric,18 and manometric 1 procedures. The
colorimetric screening method of Limperos
and Ranta 100 is adaptable to the approximate
determination of large numbers of samples
under field conditions. Other procedures involve use of the Hestrin method 75 for measurement of acetylcholine.
The restoration of plasma or of plasma
and red blood cell cholinesterase activity may
be increased by plasma or whole blood transfusions in animals without any effect on the
symptoms of poisoning or appreciable reduction in the susceptibility to further exposure. 14
Although the acetylcholinesterase of red
blood cells and the more general esterase of
the plasma are not directly related to the
signs and symptoms of organic phosphorus
poisoning, these enzymes are inhibited in a
manner essentially parallel to the inhibition
of acetylcholinesterase of nerve, muscle, and
gland. The blood enzyme levels, and particularly that of the erythrocytes, may be used
as an index of tissue enzyme levels. The
erythrocyte cholinesterase level has been
shown to correlate rather closely with the
activity of this enzyme in the brain during
both poisoning and recovery in the rat. 60
Following a single exposure, maximum depression of blood cholinesterase occurs
within a few hours. The degree of depression
varies with the amount of absorption, the
logarithm of the fraction of enzyme inhibited
being proportional to the amount of toxicant
absorbed in connection with essentially instantaneous dosage. Of course, absorption is
influenced by route, often being prolonged
for hours or even days after skin exposure.
Multiple exposures over a brief period are
partially cumulative in their effect. ExperiDurham-Hayes
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ence suggests that small multiple exposures
over an extended period are not indefinitely
cumulative in their effects but that the cholinesterase level reaches a plateau.74,135 There
is some evidence that the rate of inactivation
of tissue cholinesterase, as well as the degree
of inhibition, may influence the level of tissue
enzyme activity at which symptoms begin.
The cholinesterase activity of the red blood
cells may be gradually depressed to near zero
by repeated exposure over a period of weeks
without systemic symptoms necessarily ensuing, or without any relation to the severity
of symptoms that occur.127,135
Following exposure, the blood enzymes,
especially the erythrocyte cholinesterase, remain at a low level of activity for some time
after the disappearance of symptoms. This
lag is thought by some to indicate that cholinesterase activity is restored more rapidly in
the tissues than in the blood, although the
tissue regeneration rate is not fully known.
Chronic-feeding and certain other studies
indicate that the phenomenon may be accounted for by tolerance rather than by a
difference of recovery rate for different enzymes. 127 The adaptation to constant concentrations of acetylcholine that has been
demonstrated to occur in ganglia 98 may well
occur in other parts of the nervous system.
This adaptation almost certainly contributes
to the lack of parallelism between symptomatology and cholinesterase level.
It is true that effects of doses of anticholinesterase compounds near the fatal level are
partially cumulative if the doses are repeated
at relatively brief intervals. Thus, Callaway
and Davies 21 have found in rabbits and
guinea pigs that lowering the blood cholinesterase level to 50% of normal by either a
single dose or repeated doses of tetraethyl
pyrophosphate (TEPP) or sarin results in
an increased susceptibility of the animal to
these agents.
Plasma cholinesterase is formed by the
liver. Following cessation of exposure, plasma enzyme activity is increased by about
13% of original activity during the first day,
and more slowly thereafter, so that 30 to 40
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days are required to reach the normal preexposure level.
Once fully inhibited, the enzyme content
of a particular erythrocyte is not regenerated.
Rather, in the absence of treatment with
oximes, the rate of regeneration of redblood-cell cholinesterase reflects the replacement of red corpuscles in the circulation and
thus requires 90 to 100 days to return to
original activity after nearly complete depression. Regeneration occurs at a regular rate
of about 1% of normal per day.
Barstad 12 concluded that respiratory function should be only slightly impaired by a
peripheral cholinesterase inhibition approaching 90% and that consequently a
rather slight degree of cholinesterase reactivation at the critical site should be sufficient
to relieve the peripheral failure of respiratory movements during poisoning with anticholinesterase agents.
Measurement of Metabolites
and Their Relationship
to Symptomatology
Exposure to those organic phosphorus
compounds which, on hydrolysis, form
p-nitrophenol or one of its congeners can
be estimated by determination of these phenolic compounds in urine. 45 Although applicable to a restricted group of compounds,
this test has proved to be a more sensitive
measure of absorption than is cholinesterase
inhibition. 4 A urine test based on excretion
of organically-bound phosphorus would be
desirable, since metabolites of this type are,
of course, common to all the compounds in
this group.
Use and Action of Atropine and
Other Nonspecific Antidotes
Until recently, the most important factors
influencing survival after otherwise lethal
cholinesterase inhibition appear to be prompt
administration of atropine in sufficient dosage and artificial respiration, if required.61
The suggested dose of atropine is 2 mg.
initially, and as much as 6 mg. may safely be
given within lO minutes or more without
medical supervision. Individuals poisoned by
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anticholinesterase organic phosphorus compounds have an increased tolerance for atropine. Furthermore, a single dose of as much
as lO mg. of atropine has been inadvertently
administered intravenously to normal adults
without endangering life, although it has, of
course, produced very marked signs of overdose. In the presence of severe anticholinesterase poisoning, 40 mg. of atropine may be
given in a day without producing symptoms
of overatropinization. The low toxicity of
atropine and its effectiveness in the treatment
of anticholinesterase intoxication have been
discussed by Gordon and Frye.65
Severe symptoms of organic phosphorus
poisoning should be treated by the physician
with the intravenous injection of 2 to 4 mg.
of atropine. The effects of intravenous atropine begin in 1 to 4 minutes and are maximal
within 8 minutes. If muscarine-like symptoms are not relieved, and if signs of atropinization (dry, flushed skin and tachycardia)
do not appear, the intravenous injection of
atropine in doses of 2 mg. should be repeated
at 5- to lO-minute intervals until symptoms
are relieved or signs of atropine overdosage
appear. A mild degree of atropinization
should be maintained in all cases for 24 hours
and in severe cases for at least 48 hours.
Atropine should not be given to an anoxic
patient because of the danger of producing
ventricular fibrillation. In the cyanotic patient, artificial respiration, oxygen, or other
indicated measures should be carried out first
to correct the anoxia, and then atropine
should be given.
Atropine should not be administered for
preventive purposes in persons who anticipate exposure to anticholinesterase agents.
Its use in this manner may mask the early
occurrence of signs and symptoms of intoxication and allow the patient to expose himself
to dangerous levels of the toxicant without
warning. Wills 145 has noted that animals
given atropine before respiratory exposure
to sarin 'vapor were somewhat more susceptible to the poison than controls given no
antidote. The ineffectiveness of atropine in
this situation was interpreted as being due
to its action to prevent the bronchoconstricVol. 5, July, 1962
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tion which otherwise occurs to some degree
after inhalation of nerve gas vapor (see
"Symptoms of Organic Phosphorus Poisoning" ), there fore resulting in greater inhalation and absorption from the respiratory
tract. Patients who are sick enough to receive
atropine should be hospitalized and kept under careful observation for 24 hours; in some
instances, a marked improvement has been
noted after atropine followed later by deterioration of the patient's condition, requiring further treatment promptly.71
Ocular symptoms produced by local absorption do not respond to the systemic administration of atropine but are relieved by
the local administration of 2% homatropine
or, if severe, by the local administration of
0.5% or 1% atropineYi7 Parenteral atropine
may relieve miosis, but the effect is both irregular and transient. I f local ocular effects
are present, the size of the pupils obviously
cannot be used as an indicator of systemic
poisoning or as a gauge for atropine dosage.
If convulsions interfere with artificial
respiration and are not relieved by intravenous atropine, the patient may be given
trimethadione (Tridione), a barbiturate, or
ether. Trimethadione may be given intravenously or intramuscularly, in doses of 1 gm.,
repeated if necessary. Morphine should not
be given. The action of succinyl choline
( Suxamethonium) increases the effect of the
anticholinesterase agents, and thus the use of
this relaxant is contraindicated (see "Chemical and Physiologic Properties of Oximes").
Results of treatment using transfusion
with normal blood or even intravenous infusion of purified cholinesterase have, in
general, been disappointing.14 It is doubtful
whether these materials provide any active
enzyme to important sites in the nervous tissue. Their action in combining with any circulating poison is too little and too late to be
of value in reversing the pathology associated
with poisoning.
It is important to understand that, while
atropine is effective as an antidote, it has no
effect on the fundamental biochemical lesion
involved in poisoning by anticholinesterase
compounds. Atropine merely serves to block
Durham-Hayes
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certain actions of the excess acetylcholine
already accumulated. Atropine has no action
on the nicotonic effects of acetylcholine, including the neuromuscular block that leads
to muscle weakness, and may finally end in
death due to paralysis of the respiratory muscles.14li Although atropine specifically blocks
the muscarinic actions of acetylcholine, it is
less effective in blocking certain muscarinic
actions (such as those on the intestine and
urinary bladder) than others (such as cardiac
slowing and sialorrhea). The effects of anticholinesterases on the central nervous system
are reversed by atropine, and the increased
electrical activity of the brain, as shown by
the EEG, is returned to normal. 1li7
Tests with various synthetic parasympatholytic agents, including l-N-butylscopolammonium bromide (Buscopan) ,37 have not
shown any of these compounds to be significantly more effective than atropine in antidotal action.

Development of Specific Antidotes
Numerous investigators have sought to
find agents that would interfere in the combination of the organic phosphorus compound with cholinesterase or hasten the
destruction of the inactive phosphorylated
enzyme complex. The deVelopment of specific
antidotes of this type has been reviewed by
Davies and Green.33 The role of oximes in
the treatment of anticholinesterase poisoning
has also been reviewed by Wills 145 and by
Verhulst and Page. 141
Probably the usage of physostigmine
(eserine) and neostigmine 26,70 represents
the earliest record of such attempts. It was
found that, instead of an expected summation or potentiation of effect occurring
between DFP and physostigmine or neostigmine, prior administration of one of the latter agents protected rats against lethal doses
of DFP. It was postulated that this antidotal
effect was due to the formation between the
physostigmine or neostigmine and cholinesterase of an unstable bond which served to
protect the active site on the enzyme from
attack by the irreversible inhibitor, DFP.
The effectiveness of these particular agents
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is strictly prophylactic, and they have no
antidotal effect when given after the poison.
An additive rather than an antagonistic action was noted when physostigmine was
given after DFP 97 or parathion. 129
Somewhat later, Wilson 148,149 reported
that choline and hydroxylamine were effective
in reversing the combination between cholinesterase and certain organic Qhosphorus
inhibitors. Wagner-Jauregg and his co-workers 144 used certain metal salts and chelates
to reactivate DFP-inhibited enzyme.
The most promising development, however, is that associated with the hydroxamic
acids and oximes. 150 As pointed out above,
it has been shown that the organic phosphorus compounds inactivate cholinesterase
by forming a firm bond with the enzyme.
This combination is commonly spoken of as
"irreversible" in contrast to the combination
of cholinesterase with physostigmine or neostigmine, which can easily be reversed by
dilution or dialysis. Actually, "irreversible"
must be regarded here as a relative term. In
fact, TEPP-inactivated enzyme spontaneously recovers some of its activity in vitro
if allowed to stand in water for a sufficiently
long time. It is more difficult to reactivate
DFP-inhibited enzyme.
It would be expected that reagents (such
as esters or acids) capable of making a nucleophilic attack on the phosphorus atom
of the inhibitor-enzyme complex could regenerate the enzyme. Theory would further
predict that presence within the reactivating
molecule of a cationic structure, such as the
ammonium radical, would facilitate this reaction by acting, as does the nitrogen atom
in acetylcholine, to properly position the
molecule for its reaction with the enzyme.
The hydroxamic acids and oximes fulfill
these requirements imposed by theory by
having both nucleophilic and cationic ammonium groupings in the molecule.
The mechanism of action of oximes in regenerating inhibited cholinesterase is thought
to consist of an initial direct combination
between the organic phosphorus-inhibited
enzyme and the hydroxamic acid, followed
by a reaction in which the organic phos-
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phorus moiety is split off and hydrolyzed.
The hydroxamic acid residue undergoes a
further reaction to regenerate the active enzyme. The important thing from a practical
standpoint is that the hydroxamic acid has
a greater affinity for the phosphorus moiety
than does the enzyme.
Epstein and Freeman 46 have reported the
results of a study of the toxicity and prophylactic and therapeutic efficiency of a series
of 15 hydroxamic acids in nerve-gas poisoning in mice. Other workers at the Army
Chemical Center 39 have made and tested 22
oximes in this regard. O'Leary et al. 118 have
tested a number of oximes both singly and
in various combinations.
Of the hydroxamates and oximes tested
by various workers, the outstanding compounds are 2-pyridine aldoxime methiodide
( 2- PAM iodide) and related salts. These
compounds combine the features of low
mammalian toxicity and good prophylactic
and therapeutic efficiency against organic
phosphorus poisoning.
Details regarding usage of oximes, and
particularly of 2-PAM salts, in the treatment
of anticholinesterase poisoning are considered in succeeding sections of this review.
2-Pyridine aldoxime methyl methanesulfonate

(P2S), which is the methane sulfonate salt
corresponding to 2-PAM, has recently been
shown to be just as effective therapeutically
as 2-P AM iodide 35 and to possess the advantage of greater water solubility.34 The
methochloride salt of 2-pyridine aldoxime
(2-P AM chloride) is more stable and more
water soluble than 2- PAM iodide. The
methochloride salt is now commercially available in the United States as an investigational
drug under the trade name Protopam. * The
lactate salt has been studied by O'Leary
et alY8
In comparing the effects of these various
salts of 2-pyridine aldoxime, it is necessary
to take into account the variation in the

* From Campbell Pharmaceuticals, Inc., 121 E.
24th St., New York 10. (The use of trade names
is for identification purposes only and does not
constitute endorsement by the Public Health
Service.)
Vol. S, July, 1962
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amount of actual free base in the dosage administered. For example, 1.0 gm. of 2-PAM
chloride is approximately equal to 1.5 gm. of
2-PAM iodide with regard to content of the
active free-base, 2-pyridine aldoxime.
British workers 5,23,128 have proposed
monoisonitroacetone (MIN A) and diacetylmonoxime (DAM) as being superior to
2- PAM in combating organic phosphorus
poisoning. DAM is less toxic than 2-PAM.6
These oximes reactivate sarin-inhibited cholinesterase in vitro and are effective antidotes
for sarin poisoning in rats. Robbiger and his
co-workers 79·81 have tested a series of 18
pyridinium oximes against TEPP and DFP
both in vitro and in vivo. They reported that
certain monoximes and dioximes of polymethylenebispyridinium compounds were
from 15 to 52 times as potent as 2-PAM.
Poziomek et al.llt) have also synthesized a
number of compounds in this series. The
outstanding antidotal compound from this
group is 1,1'-trimethylene-bis(4-formyl-pyridinium bromide) dioxime (TMB_4).15,52,711.81
These other oximes have not been studied so
thoroughly as the salts of 2-PAM.
Another type of specific antidote which
should be mentioned includes compounds
which increase the hydrolytic activity of cholinesterase. Among the compounds which
have been shown in vitro to possess this sort
of activity are tryptamine,50 certain analgesics,53 and other compounds. 55 ,72,139 Most
of this work has been carried out with plasma
cholinesterase, although some studies using
the specific enzyme have been done. 11o ,134,137
There is, at present, little or no indication
that these agents would be of practical value
in the treatment of poisoning.
Ball and his co-workers 10 found that rats
which had been given a large but sublethal
dosage of aldrin were able to withstand
amounts of parathion that would ordinarily
be lethal. This protective effect of aldrin was
accompanied by an increased plasma cholinesterase level. Similar results have been noted
with other chlorinated hydrocarbon insecticides, including chlordane, dieldrin, DDT,
heptachlor, and the a and y isomer (lindane)
of benzene hexachloride (BRe) .21},115 Other
Durham-Hayes
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known hepatotoxic agents (such as carbon
tetrachloride) have a similar action. The
transitory rise in serum esterase apparently
is a temporary consequence of the tissue
damage occurring in the liver. Since the protective effect has been noted for a direct
inhibitor (TEPP) as well as for compounds
which must undergo biotransformation in
order to bet:ome toxic, a decreased activating
ability of the liver would not seem to be the
mechanism of action. The most likely possibilities appear to be an increased level of
phosphorylatable enzyme which competes
with the true cholinesterase for the inhibitor,
or an increased level of hydrolyzing enzyme
which aids in the degradation of the anticholinesterase. O'Brien 116 considers the latter possibility to be more likely.
Many of the organic phosphorus compounds (including parathion, the other phosphorothioates, and some phosphoroamidates)
become potent anticholinesterase agents only
after bioactivation by the liver. 116 It has
proved possible to protect animals from compounds of this type by blocking the activating
enzymes present in the liver. Thus, Davison 36
was able to protect mice from poisoning by
octamethyl pyrophosphoramide (OM P A)
but not by parathion through prior administration of the liver microsome inhibitor SKF
525A (,8-diethylaminoethyl diphenylpropylacetate hydrochloride) . O'Brien and
Davison 117 studied other liver microsome inhibitors, but found SKF 525A to be the best
of 12 agents tested. They confirmed the failure of SKF 525A to protect against parathion but found that it antagonized Guthion
insecticide poisoning. The lack of effectiveness of SKF 525A against parathion poisoning has not been satisfactorily explained. The
failure does not seem to represent a general
ineffectiveness against phosphorothionates,
since the LD50 of Guthion was increased.
In connection with this effect on the enzyme
system which activates the organic phosphorus insecticides, it is interesting to note
that compounds are also known which inhibit
the enzyme systems that detoxify the organic
phosphorus compounds. Among the compounds producing this effect are certain of
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the organic phosphates themselves. Thus,
when given in combination, the resultant toxic
action of certain of the organic phosphorus
compounds is greater than would be expected on the basis of simple additive effect.1I6
This potentiation was first reported for malathion plus ethyl-p-nitrophenyl thionobenzene
Chemical Name

phosphonate (EPN),1i6 while the maximum
synergistic effect (88 to 134 times.) noted has
been observed with malathion plus triorthotolyl phosphate TOTP .109 The mechanism by
which potentiation occurs has been elucidated
and appears to involve the interference of
one compound with the metabolism of the

Common Name

Structural Formula

B;ydroxyl amine

Pyridine-2-alddxime
methiodide

2-PAM or
2-PAM iodide

Pyridine-2-aldoxime
methochloride

2-PAM chloride
or Protopam

Pyridine-2-aldoxime
methyl methanesulfonate

P2S

Diacetylmonoxime

DAM

MOnoisonitrosoacetone

I,ll-trimethylene
bis(4-formyl-pyridinium
bromide) dioxime

Same as above except
chlorine salt

MINA

THB-4 or
TMB-4 dibromide

Chemical name, common name, and structural formula of oximes used as antidotes in poisoning by anticholinesterases.
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Toxicity of Oximes to Experimental Animals

Compound
2-P AM Iodide
2-P AM Iodide
2-P AM iodide
2-PAMiodide
2-P AM iodide
2-PAM sulfonate
2-PAM chloride
2-P AM chloride
TMB-4 dibromide
TMB-4 dlcbloride
TMB-4 dichloride

Species

Sex

Mouse
Mouse
Mouse
Meuse
Mouse
Mouse
Mouse
Rabbit
Mouse
Mouse
Rabbit

Mixed
Mixed
Unstated
Unstated
Unstated
Unstated
Unstated
Mixed
Unstated
Unstated
Mixed

second.27.28.109 Seume and O'Brien 133 have
reported that inhibition of carboxyesterase
and carboxyamidase is important in potentiation of these compounds.
A potentiating effect between certain of the
organic phosphorus insecticides and some
phenothiazine-derived tranquilizers has been
found to occur in rats 64 and has been suspected to occur in man. 3
It has been noted that the signs and symptoms of parathion poisoning were intensified
and prolonged in a patient who was given
succinylcholine for control of convulsions. 12o

Route
Intraperitoneal
Intraperitoneal
Intr" peritoneal
Subcutaneous
Intravenous
In tra ven ous
Intravenous
Intravenous
Intravenous
Intravenous
Intravenous

LD ..
mg/kg

Reference

136± 6
223±10
209±22
140±15
145± 8
118±13
115± 3
95
53± 5
57± 1
44

92
102
160
160
118
118
118
118
118
118
118

doses are given, death usually occurs within
10 to 20 minutes and is due to respiratory
failure. Generalized clonic convulsions and
gasping respiratory movements are seen.
Generalized skeletal muscle tremors continue
for a few minutes after cessation of respiration. The similarity of this symptom picture
to that seen in organic phosphorus poisoning
leads one to suspect that the mechanism of
toxic action of 2-PAM may involve its observed capacity to inhibit cholinesterase in
excess dosages (see further details on
page 34).
In man, side-effects from the oximes
Chemical and Physiologic
2-PAM iodide, 2-PAM chloride, and diaProperties of Oximes
cetylmonoxime (DAM) have been minimal
The chemical structure of 2-PAM iodide in normal subjects and practically nonexistent
is shown in the Figure. The similarity of in people who were poisoned.68.69.87 Rapid
the aliphatic portion of this molecule to intravenous injection of 2-PAM iodide has
hydroxylamine is apparent. Pure 2-PAM produced transient mild weakness, diplopia,
iodide is a yellow, crystalline solid which de- blurred vision, dizziness, impairment of accomposes at 219 C. It is soluble in water up commodation, and occasionally headache,
to about 5% and practically insoluble in ethyl nausea, and tachycardia. 87 A few patients
alcohol. Themethanesulfonate salt (P2S) is given 2-PAM iodide have complained of a
soluble in water up to about 40%.34 The bitter taste that no doubt resulted from the
chloride is soluble in water to the extent of iodine moiety of the molecule; 2-PAM iodide
has also produced an allergic rhinitis and a
1.0 gm. in less than 1.0 ml.
The toxicity to laboratory animals of vari- feeling of fatigue in the jaws,11a
ous oximes as determined by a number of
Intravenous injection of DAM has caused
different investigators is summarized in the a burning sensation at the site of injection
Table. It can be seen that the estimate of the radiating up the vein, giddiness, drowsiness,
intraperitoneal LDso of 2-PAM iodide to a sensation of warmth and tingling in the
mice ranges from 136 to 223 mg. per kilo- abdomen and chest, tachycardia, mild posgram, and the intravenous LD50 ranges from tural hypotension,68 and occasionally bitter
44 to 145 mg. per kilogram for mice and taste, paresthesias and decreased position
rabbits. The toxicity of the compound, while sense in the extremities, decreased sweating,
important, is not especially great. When lethal transient loss of consciousness, clonic moveDurham-Hayes
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ments of the head, and decreased amplitude
of the electroencephalogram and of the Twave segment of the electrocardiogram. 87
Many of the oximes liberate cyanide in the
body and also on long standing in vitro. 8,11l
When there is doubt concerning the integrity
of a 2-PAM preparation, particularly solutions of old or uncertain age, a simple test
for free cyanide should be carried out.
lt should be noted that 2- PAM salts have
at least 3 actions which may be of importance
in their effect on animals poisoned by organic
phosphorus compounds. These actions are:
1. Reactivation of inhibited cholinesterase.
2. Reaction with and inactivation of the organic
phosphorus molecule.
3. Inhibition of cholinesterase, especially in excess
dosage.

The reactivation of inhibited cholinesterase
is the dominant effect of 2-PAM in poisoned
animals. In vitro, 2-PAM is a very powerful
reactivator. At a concentration of 1O-5M.,
2-PAM iodide reactivates as much as 80%
of alkyl phosphate-inhibited enzyme within
1 minute. 154 ,31,23 The diisopropyl phosphorylated enzyme is reactivated more slowly and
less completely than the diethyl substituted
cholinesterase. 77 In a comparative in vitro
study of 2-PAM iodide, DAM, and monoisonitroacetone (MIN A), Cohen and Wiersinga 24 found that 2-PAM iodide was the
most efficient reactivator, followed closely by
MINA. The reactivation by DAM was slow
when compared with those of the 2 other
oximes. In a later paper, Cohen and Wiersinga 25 theorized that the antidotal efficacy
of DAM was primarily due to its ability to
inactivate the organic phosphorus molecule
rather than its capacity to regenerate inhibited
cholinesterase. Rajapurkar and Panjwani 124
suggested that DAM had an antiacetylcholine
effect, like that of atropine. Their hypothesis
was based on study of ciliary movement in
the frog esophagus. This preparation has
been shown to contain the acetylcholinecholinesterase-choline acetylase system, but
no nervous tissue. DAM produced slowing
of the ciliary movement similar to that produced by atropine or curare. The action was
the same in eserinized or normal cilia. Thus,
apparently neither a central mechanism nor a
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reactivation of inhibited enzyme was responsible for the effect of DAM in this instance.
Kewitz 90 has shown that 2-PAM iodide
reactivates the esterase activity of diaphragm
in the living animal poisoned with paraoxon
or DFP, but not OMP A. These results parallel those obtained in vitro with the same compounds and afford good evidence that the
antidotal properties of 2-PAM depend upon
reactivation of inhibited cholinesterase.
Cohen and Wiersinga 215 reported that both
MINA and 2-PAM iodide rege'1erated diaphragm cholinesterase in vivo in sarinpoisoned rats. Inhibited brain cholinesterase
was reactivated by MIN A only.
Some workers 7,78 have not been entirely
satisfied with this explanation for the antidotal efficacy of 2-PAM, and, in support of
their view, point out that the therapeutic
efficacy and in vitro cholinesterase reactivating power of the oximes do not correlate
very closely. One would do well to remember,
however, that the other 2 actions of oximes
(numbers 2 and 3 above) must also be considered and may explain the observed lack
of correlation.
In contrast to the marked rise of enzyme
activity in blood and muscle following the
administration of 2-PAM, little or no effect
has been noted on inhibited brain cholinesterase. 78 ,128,1l0,91,25 This failure of 2-PAM to
reactivate brain cholinesterase has usually
been ascribed to a supposed inability of the
oxime to pass the blood-brain barrier. In
earlier work, Koelle and Steiner 96 had shown
that quaternary nitrogen compounds penetrate the blood-brain barrier with difficulty.
However, even when administered intracisternally, P2S had no effect on the central
actions of sarin. Holmstedt 84 considered that
the observed failure of 2-PAM iodide to
restore respiration depressed by anticholinesterase was due to its inability to penetrate
the blood-brain barrier. Jager et a1. 88 found
low concentrations of 2-P AM iodide in the
brain of 2 rabbits infused with this antidote.
Wilson 152 has attempted to overcome this
difficulty by using the fat-soluble dodecanoic
acid analogue of 2-PAM with only partial
success. In contrast to these results, RosenVol. 5, July, 1962
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berg 126 has noted in vivo reactivation of
brain cholinesterase by 2- PAM iodide after
paraoxon poisoning in the rabbit. Rosenberg
considered that the differences between his
results and those of others cited above might
be due to species variation or to the use of
different extraction procedures. Differences
in dosage levels of 2- PAM may also have
been a factor, since Rosenberg gave very high
dosages (up to 250 mg. per kilogram).
The marked effectiveness of 2-PAM
iodide, 2-PAM chloride, and TMB-4 in
poisoning by Phospho line Iodide in mice is
considered to be related to the fact that phospholine, in contrast to other organic phosphorus cholinesterase inhibitors, contains a
quaternary nitrogen atom, and thus, like the
quaternary oximes, fails to pass the bloodbrain barrier.911
TMB-4 did not reactivate brain cholinesterase activity in rats poisoned with DFP
or sarin.51
Jager et al. 88 were not able to demonstrate
2- PAM iodide in the cerebrospinal fluid in a
man who received 44 mg. per kilogram of
this oxime intravenously. However, rapid returns to consciousness following administration of 2-P AM iodide have been noted in
patients poisoned with parathion. 811 ,49,121 This
clearing of consciousness would seem to be
an indication that the drug has access to the
brain in man. The practical clinical result
may be further evidence for species variation
in the action of 2-PAM.
In contrast to the peripherally-acting quaternary oximes (2-PAM and TMB-4), the
nonquaternary oximes have a predominantly
central action. 146 ,19 DAM has been shown
to penetrate the blood-brain barrier and effect
some reactivation of brain cholinesterase. 88 ,43
However, DAM in large doses has produced
coma in man. 87
O'Leary et al. 118 have reported that atropine and a combination of a mono quaternary
and a bisquaternary oxime were superior to
atropine with either single type of oxime in
dogs and rabbits poisoned with sarin or
tabun. AI: 1 mixture of 2-P AM chloride and
TMB-4 dichloride was the most effective
combination tested. Edery and SchatzbergDurham-Hayes
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Porath 44 have noted synergIsm between
2-P AM and DAM.
At any given dosage with any given inhibitor and reactivator, the extent of reactivation
of cholinesterase activity that occurs depends
upon how long the inhibitor and enzyme have
been left in contact. 76 Hobbiger theorized that
the phosphorylation of cholinesterase led initially to an unstable phosphorylated enzyme
which gradually changed to an irreversibly
phosphorylated enzyme. This phenomenon
has been termed "aging" by O'Brien 116 and
has been shown to occur in vivo 78 as well as
in vitro. 151 ,32 Aging occurs rather slowly with
methylphosphorylated cholinesterase, but
more rapidly with diethyl- or diisopropylsubstituted enzyme. 32 These results indicate
that the oximes might be less effective in
regenerating- cholinesterase inhibited during
repeated exposure than that inactivated after
a single exposure.
The use in vitro of a reactivator in the
routine cholinesterase test has been proposed
to allow determination of both inhibited and
normal enzyme levels in a single blood sample
from a patient in whom poisoning is suspected. 3 The occurrence of aging would seem
to make achievement of this objective unlikely in connection with repeated exposure;
but it should be possible, by use of a similar
technique, to differentiate between an inhibition of cholinesterase due to a recent, acute
exposure and a depression due to a previous
or repeated exposure.
Direct reaction between 2- PAM and the
organic phosphorus molecule has been shown
to occur. 143 ,T7 The importance of this reaction
in either the prevention of dermal absorption
or local effects of anticholinesterase compounds or both has been discussed by
Summerson. 159 Kewitz, Wilson, and Nachmansohn 93 have, however, pointed out that
it is unlikely that the direct reaction is an
important factor in the antidotal action on
systemic effects in vivo, since in vitro experiments have shown that this direct reaction
is very slow at concentrations obtainable
under physiological conditions. These authors
note that even with a 1O-3M. concentration
of 2-PAM iodide at 25 C, pH 7.8, only about
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1% of diethyl p-nitrophenyl phosphate
(Paraoxon, 1O- 4 M.) reacts per hour. Cohen
and Wiersinga 25 found that both DAM and
MINA detoxified sarin during in vitro incubation. No detoxication of sarin by 2-PAM
iodide occurred. These authors suggested
that DAM acts mainly by virtue of direct
reaction with the toxicant, that 2-PAM acts
primarily by reactivating inhibited enzyme,
and that MINA shows both types of activity.
At sufficiently high dosages, 2-PAM iodide
is capable of inhibiting both serum and erythrocyte cholinesterase in vitro. 8'2.T7.68 Although
the antidotal dosages which have generally
been used are below the toxic level, there
would seem to be, on the basis of studies
reported by Loomis,102 a definite possibility
of lessened antidotal effect if greater than
the optimal dose of 2-PAM were given. This
author noted that dogs given an intravenous
dose of 60/Lg. of sarin per kilogram required
more than 240 minutes to recover their normal response to injected acetylcholine. Following intravenous administration of 10, 25,
or 250 mg. per kilogram of 2-PAM iodide
to normal dogs, <2, 3, and > 120 minutes,
respectively, were required for return of the
normal acetylcholine response. The same
dosage levels of 2-P AM iodide when given
to sarin-poisoned dogs, produced return to
normal acetylcholine response after 40 to 45,
80 to 100, and > 120 minutes, respectively.
These results indicate that 2-PAM iodide
is a cholinesterase inhibitor, that 10 mg. per
kilogram was the optimum antidotal dosage
under the condition of the test and that larger
doses were less effective.
Woodard 158 gave 50 mg. per kilogram of
2-P AM iodide to cattle intraperitoneally and
intravenously. This dosage produced some
restlessness and mild abdominal distress, but
the signs were mild and of short duration.
One sheep given 25 mg. per kilogram of
2- PAM iodide intravenously showed the
same signs as the cattle, plus an increased
respiratory rate and excessive salivation.
No change in erythrocyte cholinesterase level
was observed in any of these animals.
The cholinesterase inhibitory activity of
2-PAM has also been noted by Bergner and
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Wagley.1 6 These workers reported that
2- PAM iodide in high concentration in vitro
had a dual effect on motor end-plate cholinesterase previously inactivated by TEPP.
The 2- PAM iodide reactivated the enzyme
and, if allowed to remain in contact with the
preparation, inhibited the reactivated enzyme.
It is important to note that in poisoned
people given therapeutic doses, the inhibition
of cholinesterase by 2-PAM is trivial, while
the release of enzyme inhibited by the organic
phosphorus compound is highly significant.
Kewitz et al.lI3 have carried out experiments which show that 2-PAM does not have
an atropine-like action. In studies on the
blood pressure of eviscerated cats, the effect
of acetylcholine was not modified by 2-PAM
iodide, even when large doses were used;
this effect was completely abolished by a small
dose of atropine, however. After 100 mg.
per kilogram of 2-PAM iodide, these authors
reported a rise in blood pressure from 120
to 160 mm. Hg which lasted 15 to 20 minutes
and was abolished by atropine. This effect
from the very large dose of 2-PAM iodide
was not further studied. Possibly, it was a
reflection of the cholinesterase inhibitory
effect of 2-PAM.
Both 2-PAM iodide and DAM, when injected intravenously in large doses, have a
direct depressant action on the respiratory
center. 156
The duration of action of a single dose of
2-PAM has been studied by Kewitz et al.lI3
Following intraperitoneal dosage, 2-PAM
iodide reached its maximum effect in rats
within 30 minutes and had declined to about
50% of maximum effectiveness at the end
of the first hour. A further decline in activity
took place during the second hour, but even
at the end of 2 hours, some protective effect
was still evident. Following intravenous
dosing, 2-PAM iodide appears to be well
dispersed in all body tissues with the exception of the brain. 88 These same authors found
that 2- PAM iodide was rapidly excreted in
man following intravenous dosage. The halflife was 0.9 hours. Excretion was primarily
by the kidneys. In nephrectomized dogs and
rats and in a patient with chronic nephritis
Vol. S, July, 1962
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and azotemia, excretion was retarded. In
vitro, 2- PAM iodide was metabolized aerobically by rat liver slices.
P2S is also rapidly excreted in man following intravenous dosing.136 Absorption of P2S
after intramuscular or oral administration
was not satisfactory.
DAM is excreted somewhat more slowly
in man than is 2-PAM iodide. 88 The half-life
for the former compound is 7.2 hours. Relatively little of the DAM could be recovered
from the urine. Apparently, the liver is of
major importance in the metabolism of
DAM.311,88
Loomis 103 has tried 2-P AM in the treatment of local ocular effects of TEPP and
sarin in rabbits. He found that 2-PAM
iodide applied locally was very effective in
reversing miosis induced by organic phosphorus compounds. The reversal was brought
about by 2- PAM iodide in 2 to 3 hours;
whereas, if allowed to remit spontaneously, it
required from 24 to 48 hours or even longer.
The most effective dosage form was a petrolatum-based ointment, containing 0.1 % of
2-PAM iodide. In contrast to Loomis' results,
Kewitz et al.1l3 reported that local application
of 2-PAM iodide had no effect on a rabbit's
pupil constricted by placing diethyl p-nitrophenyl phosphate in the eye. However, intravenous injection of 50 mg. per kilogram of
2- PAM iodide brought the pupil back to
normal size and restored reactivity to light
within 5 minutes. The formulation in which
2- PAM iodide was used for local application
was not stated. It may be that the lack of
effect was due to use of a water solution of
2-PAM iodide rather than an oil-based preparation.
Application of 2- PAM iodide 82,147 and
MINA 82 relieves the neuromuscular block
caused by anticholinesterases. Grob and
Johns 68 reported that DAM reversed the
local neuromuscular block produced by anticholinesterases in man, but Edery 43 did not
note this effect in the cat or the rat. In this
connection, it would be of interest to study
the effect of these oximes on the paralysis
caused by certain organophosphorus compounds. Holmes and Robins 82 have stated
Durham-Hayes
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that the reversal of neuromuscular block is
due entirely to a reactivation of inhibited
cholinesterase in the muscle. Wislicki 156
noted that DAM reduced direct and indirect
muscular excitability to a marked extent,
while with 2- PAM iodide these effects were
slight and were obtained only after intraarterial administration. Application of 2PAM antagonizes the block caused by the
competitive type of blocking agent, such as
curare, and it intensifies the effect of suxamethonium. DAM has no definitive influence
on the former but prolongs the action of the
latter. Neostigmine, unlike atropine, antagonizes the depression of muscle excitability by
DAM but has no marked effect on the action
of 2-PAM.
Longo et al.1° 1 have reported that the
threshold level of sarin necessary to produce
a "grand mal" electroencephalographic pattern was increased about threefold by 2-PAM
iodide. However, 2-P AM iodide had no effect
on the early phase of desynchronization of
the electroencephalogram.
Antidotal Efficacy of Oximes in Poisoned
Experimental Animals
There are now in the published literature
numerous reports giving results of the usage
of 2-PAM salts and other oximes in laboratory animals poisoned with various organic
phosphorus compounds. The compounds
studied have included demeton,130 DFP,1l3,20,
78,52 Diazinon,131 dime fox, 131 dimethoate,131
endothion,54 Ethyl Guthion,130 Guthion,l30
methyl demeton,54 methyl parathion,131 morphothion,130 paraoxon,1l2.93,17,78 parathion,17,
155,54,131 phencapton,131 Phosdrin,130 phosphamidon,l3o,86.108 Phospholine Iodide,99 sarin,t OMPA,93 tabun, 20.155.52 TEPP,78.155.
35.52 and phorate. 130 Most workers have
found that the combination of oxime and
atropine is superior to either antidote used
alone. However, Sanderson 130 did not note
any increased benefit of an oxime (2-PAM
iodide or P2S) plus atropine in comparison
with atropine alone in rats given oral doses
of 10 organic phosphorus and carbamate in-

t References 102, 6, 147, 155, 35, 145, and 52.
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secticides. With oral Guthion, Ethyl Guthion,
demeton, and morphothion, 2- PAM iodide
apparently reduced the beneficial effect of
atropine. This author did note potentiation
between atropine and oxime in some instances
when the poison was given intraperitoneally.
Sanderson and Edson 131 concluded that the
relative effectiveness of oxime therapy with
different organic phosphorus insecticides depends on the proportion of reversible cholinesterase inhibition present, as predicted on
the basis of the structure and duration of
action of the anticholinesterase compound.
The efficacy of 2- PAM in the treatment of
poisoning varies from compound to compound, but it has shown some effectiveness
in the case of all the materials listed above
with the exception of dimefox, dimethoate,
and OMPA. In this connection, it is interesting to note that Tammelin and Enander 138
reported synthesis of an organic phosphorus
compound (cholinyl methylphosphonofluoridate) which caused an inhibition of cholinesterase that could not be reversed in vitro
by 2-PAM iodide.
Woodard 158 has reported results of studies with 2- PAM iodide in cattle and sheep
poisoned with organic phosphorus illsecticides. N either atropine nor 2-P AM iodide
alone was a satisfactory antidote in these
animals. A combination of 2-PAM iodide
and atropine gave good results on cattle
poisoned with parathion or Diazinon, but not
on cattle poisoned with malathion or on sheep
poisoned with parathion.
It appears likely that different oximes have
some specificity not only for different organic phosphorus compounds but also for
different species.
The effectiveness of oximes as antidotes
has also been tested in poisoning by certain
other cholinesterase inhibitors which are not
organic phosphorus compounds. The use of
2-P AM iodide has been reported to be ineffective, if not detrimental, in the treatment
of poisoning by the carbamate insecticide
Sevin in rats and dogS. 22 ,180 On the other
hand, poisoning in the rat by the carbamate
insecticides Isolan and Dimetilan was benefited by 2- PAM iodide. 130 It has also been
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shown that 2- PAM iodide and DAM reverse
the physiological effects of neostigmine
(which is a substituted carbamate.) and several of its derivatives. 68

Application of 2-PAM in
Poisoning in Man
The oxime 2- PAM has now been used in
the treatment of poisoning in man in a number of instances.
Namba and Hiraki 114 have reported a
series of 5 cases. All of these cases were
classified by the authors as serious-indicating a potentially fatal outcome-if untreated.
However, one of those patients was already
asymptomatic at the time he received 2- PAM
iodide. A second patient who had previously
received 10 mg. of atropine showed no clinical improvement immediately after receiving
100 mg. of 2-PAM iodide intravenously. He
did, however, improve about 3 hours later
(6 hours after onset of symptoms). A third
case was given ten 100-mg. intravenous doses
of 2-P AM iodide during a period of 3.5
hours. By the end of this time, all symptoms
had disappeared. A fourth patient became
symptom-free after doses of 500 and 400
mg. of 2-PAM iodide, separated by 10 minutes. The fifth case received 1 gm. of 2P AM iodide intravenously, which the authors
considered to represent the ideal treatment.
Within 21 minutes, all the symptoms in this
fifth case, including muscle fasciculations,
had disappeared.
In 3 of the 5 cases cited above, the erythrocyte cholinesterase level returned to normal
in 10 minutes, 40 minutes, and 3.5 hours,
respectively. In the fourth case the recovery
of the red-cell enzyme was signific;mtly more
rapid than that of the untreated control. In
the fifth case, it is not clear from the data
presented that the red-cell enzyme level was
ever significantly depressed. No immediate
effect of 2-PAM iodide on plasma cholinesterase was evident, but in all treated cases
studied, this enzyme returned to a normal
level more rapidly than did the untreated control.
It should be especially noted that the recovery in 4 out of 5 of these human cases was
Vol. 5, July, 1962
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after 2-PAM iodide alone. Only 1 of the
patients received a combination of 2-P AM
iodide and atropine. The work with experimental animals cited above would lead one
to expect that a combination of both drugs
would be more effective than either alone.
In a later paper, Namba 112 reported the
results of the use of 2- PAM iodide in an
additional 26 cases of accidental parathion
poisoning and in 2 cases of attempted suicide
by ingestion of parathion. The accidental
poisonings were treated with 1 to 2 gm. of
2-PAM iodide intravenously. Marked improvement was noted within 30 minutes.
Pallor was the only symptom remaining in
5 cases, miosis in 3 cases, and difficulty of
speech and tachypnea in 2 cases. These remaining symptoms had cleared within 1 hour
after treatment. Complete recovery of consciousness occurred in 5 cases. Symptoms
such as nausea, headache, dizziness, and
numbness of extremities did not respond as
well to 2-PAM as did the others just mentioned. Some of these effects persisted for as
long as 1 week. To be effective in cases of
ingestion of parathion, it was necessary to
give very large doses of 2-PAM. Continuous intravenous infusion of 2- PAM at the
rate of 0.5 gm. per hour is preferred by Dr.
N amba. One patient received a total dose
of 40.5 gm. of 2-PAM iodide, recovering
without apparent ill effect. Namba 112 mentioned exploratory study of the use of 2PAM for the prophylaxis of parathion
poisoning.
Funckes 62 has reported the successful
treatment with 2-P AM iodide and atropine
of a severe case of occupational parathion
poisoning. This patient was given 1 gm. of
2-P AM iodide intravenously about 1 hour
after illness began, and he improved dramatically within 10 minutes. Although blood
cholinesterase levels prior to administration
of 2-PAM iodide were not determined, the
enzyme activities after the drug was given
indicated reactivation of erythrocyte cholinesterase (0.32 ~ pH per hour) as measured
by the method of Miche1 107 and expressed
in terms of change of pH per hour; there was
Durham-Hayes

little or no effect on plasma enzyme (0.04
pH per hour).
Quinby and Clappison 121 used 2-P AM
iodide in the treatment of a 2-year-old child
who ate dirt contaminated with parathion.
The child was given an intravenous dose of
250 mg. of 2- PAM iodide following repeated
doses of atropine. The critically ill, unconscious child returned to an almost normal state
in less than 20 minutes after the oxime dosage
was given. The levels of both plasma and
erythrocyte cholinesterase were near 0 before
2-PAM, but 20 minutes after its administration, the erythrocyte cholinesterase level had
returned to within the range of normal. The
reactivation of plasma enzyme level was much
slower, the normal level being reached between the third and nineteenth days. p-Nitrophenol was excreted in the urine quite rapidly,
clearing in about 30 hours from ingestion.
Schvartsman and his colleagues 132 treated
a child who had ingested a commercial solution of parathion. The treatment included
milk, atropine, stropanthin, and 300 mg. of
2- PAM sulfonate. The child regained consciousness and began to improve after treatment; he was discharged from the hospital
after 3 days.
Karlog et al. 89 have reported the treatment
with atropine and 2-PAM iodide of a patient
who attempted suicide by taking an estimated
1.75 gm. of parathion by mouth. This patient
was given very large doses of atropine
beginning soon after poisoning. His respiration ceased, and he was given artificial respiration for 5 hours after poisoning. He was
not given any 2- PAM until 2.5 days after
poisoning. During the next 12 hours he was
given 3.5 gm. of the antidote. Each dose of
2-P AM iodide produced transitory rises in
plasma and erythrocyte cholinesterase activity which persisted for only a few hours,
but the patient eventually recovered.
Rosen 1'25 treated with 2- PAM iodide a
young man who was poisoned by accidentally
spilling a gallon bottle of parathion concentrate on his hands. This patient was given
adequate doses of atropine during the first 18
hours after poisoning, and by the end of this
time he was symptom-free except for per~
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sisting muscular weakness. After 2-P AM
was administered, prompt improvement in
muscle strength was noted.
One of the most severe poisoning cases
treated with 2- PAM is that reported by
Imo. 85 A young girl drank parathion with
suicidal intent. She was found unconscious,
in convulsions, foaming at the mouth, and
unreactive even to the strongest stimulus.
She had almost no pulse and was cyanotic and areflectic. Atropine, artificial
respiration, Stereofundin, and nikethamide
(Coramine) were given, and spontaneous
respiration was restored. About 9 hours later,
500 mg. of 2-PAM iodide was given. Within
1 hour, the patient regained color, became
completely conscious, and her pupillary reflexes returned to normal. Further recovery
was uneventful.
Other instances of parathion poisoning
treated with 2- PAM include a series of 10
cases (of which 6 were attempted suicide)
reported by Erdmann. 47 Three of these patients recovered, 3 died, and in 4 cases the
outcome is not indicated.
Erdmann and Latki 48 have used 2- PAM
iodide in the treatment of a case of poisoning
from inhalation of DFP. The administration
of atropine and 2-PAM iodide (2 doses of
500 mg. each, orally, 2 and 5 hours after exposure) produced prompt remission of
symptoms with the exception of miosis, which
persisted for 8 to 10 days and led to a severe
conjunctivitis. Some increase in erythrocyte
cholinesterase activity was noted after 2PAM, but the enzyme level did not return to
normal until about 30 days later.
In 2 cases of moderately severe 2-carbomethoxy-l-methyl-vinyldimethyl phosphate
(Phosdrin) poisoning, Funckes 63 noted a
less dramatic clinical response to 2-P AM
iodide than in the case of parathion poisoning.
Both of the 2-P AM -treated Phosdrin cases
continued to show symptoms of poisoning for
several hours after receiving the antidote.
However, the erythrocyte cholinesterase level
was significantly increased, and the plasma
enzyme was regenerated to a lesser degree
after 2-P AM therapy.
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A formulating plant worker studied by
Quinby and Congdon 122 became poisoned
while working with parathion. He had a very
low blood cholinesterase level (plasma 0.10
and erythrocytes 0.08 A pH per hour) during
his acute illness and was given atropine therapy. His gastrointestinal complaints, particularly anorexia and nausea, as well as
weakness, headache, and malaise, persisted.
He continued to work in the plant, although
presumably he was removed from direct contact with insecticides. However, his urinary
p-nitrophenol excretion indicated continued
exposure to parathion. Because of these continuing symptoms, and in an attempt to raise
his blood cholinesterase level sufficiently to
permit his safe return to his regular work,
this man was given 1 gm. of 2-PAM chloride
6 days after his acute illness. The antidote
had little or no effect on his blood cholinesterase level, but he felt much better the next
mormng.
It is apparent from brief case reports that
the use of 2-PAM in combination with
atropine is considered effective and is routine
in the treatment of poisoning by organic phosphorus insecticides in Israel. 2
Suggestions for Treatment
The following suggestions are provided as
a guide to the physician who may be called
upon to treat persons poisoned by anticholinesterase compounds:
I. In very severe cases, the order of treatment
should be as follows:
(1) ARTIFICIAL RESPIRATION, preferably by mechanical means.
(2) ATROPINE, 2 to 4 mg. (1/30 to 1/15
grain) intravenously as soon as cyanosis
is overcome. Repeat at 5- to lO-minute intervals until signs of atropinization appear (dry, flushed skin and tachycardia
as high as 140 per minute).
(3) 2-PAM, 1 gm. slowly, intravenously.
(4) DECONTAMINATION of the skin,
stomach, and eyes as indicated.
(5) SYMPTOMATIC TREATMENT.
II. In the more usual case, proceed as follows:
(1) ATROPINE, 1 to 2 mg. (1/60 to 1/30
grain), if symptoms appear. If excessive
secretions occur, keep the patient fully
atropinized. Give atropine sulfate every
hour up to 25 to 50 mg. in a day.
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(2) DECONTAMINATION of the skin,
stomach, and eyes as indicated.
(3) 2-PAM, 1 gm. slowly, intravenously if
the patient fails to respond satisfactorily
to atropine.
(4) SYMPTOMATIC TREATMENT.

It will be noted that this recommended
dosage of atropine is greater than that conventionally employed for other purposes but
is within safe limits. People poisoned by
anticholinesterase organic phosphorus compounds have an increased tolerance for atropine. For additional discussion of atropine
usage, see "Use of Atropine and Other Nonspecific Antidotes," above.
Although different oximes offer somewhat
different therapeutic possibilities, 2- PAM appears to be the most generally useful oxime
now available. There appears to be no essential difference in the effects of the different salts of 2-PAM, and 2-PAM chloride
does have the advantage of greater solubility
and lack of iodine taste as compared to 2PAM iodide, which used to be more easily
available. A dosage of 10 to 20 mg. per kilogram has proved a safe but generally effective
level. As a round figure, 1 gm. should be an
average adult dose. Intravenous administration is recommended to obtain rapidity of
action. Since 2-PAM is excreted rapidly,
repeated doses may be necessary, particularly
in cases involving parathion or other compounds that must undergo bioactivation before becoming toxic. It is important to note,
however, that the only known signs or symptoms of overdosage with 2-PAM are identical
to the manifestations of poisoning with anticholinesterases. 2-PAM should be administered in conjunction with adequate doses of
atropine. Other supportive treatment, including particularly artificial respiration, should
also be carried out as required.
The value of 2-PAM is most thoroughly
established in connection with the treatment
of poisoning by parathion. When used in
cases of poisoning by other organic phosphorus insecticides, it should be with the
awareness that it may be somewhat less effective. In fact, 2-PAM appears to be ineffective in treating poisoning due to OMPA.
Durham-Hayes
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Until 2-PAM is freely available for prescription it is recommended that the limited
supply not be drawn upon in cases of mild
poisoning or in cases that show a completely
satisfactory response to atropine.
Consideration should be given to local application of 2-PAM to the skin to reduce
dermal absorption in exposed persons, and
to the eyes to reverse organic-phosphorus-in.duced miosis. The use of 2-PAM for the
prevention rather than the treatment of systemic poisoning has been proposed. These
procedures seem to be safe on the basis of
limited studies with experimental animals,
although their effectiveness has not been
proved. These procedures are strictly exploratory, while the value of 2-PAM for
treatment of systemic poisoning, especially
by parathion, is established.
N ever give morphine, theophylline, or
theophylline-ethylene-diamine (aminophylline) to a patient poisoned with an anticholinesterase agent. Do not give atropine to a
cyanotic patient; give artificial respiration
first, and then give atropine. Large amounts
of intravenous fluids are generally contraindicated because of excessive fluid in the
respiratory tract. Tranquilizers should be
used with great caution; they are seldom
indicated at all. Succinyl choline should not
be given.
If pulmonary secretions have accumulated
before atropine has become effective they
should be removed by suction and a catheter.
If the stomach is distended, empty it with a
Levine tube.
If the patient has not yet shown symptoms
or they have been allayed by treatment, he
must be completely and quickly decontaminated. Remove the patient's clothing and,
with due regard for his condition at the
moment, bathe him thoroughly. Remove any
visible insecticide gently with a generous
amount of soap and water or other detergent
if available. Avoid abrasion. When the skin
appears clear, bathe or swab with ethyl alcohol. Parathion and many of the other organic phosphorus insecticides are very much
more soluble in alcohol than in water, and
significant amounts can be washed from skin
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that has been scrubbed several times with
soap and water.
I f there is any suspicion that the poison
has been ingested or inhaled and if the patient
is still responsive, induce vomiting, give some
neutral material such as milk or water, and
induce vomiting again. The reason for mentioning inhaled material is, of course, that a
large portion of it is deposited in the upper
respiratory tract and subsequently carried to
the pharynx and swallowed. Nausea may be
anticipated on the basis of the systemic action
of these compounds, but if vomiting is not
profuse, gastric lavage may be used. Experiments have indicated that vomiting induced
immediately or even 1.5 hr. after ingestion is
more effective than gastric lavage in removing
pOlson.
It must be kept in mind hOW little parathion
is necessary to produce poisoning by the oral
route. Repeated dosage at the rate of 7.2
mg. per man per day led to moderate reduction of blood cholinesterase activity.44a A
dose of 25 to 50 mg. was fatal to a child,132a
and a dose of 120 mg. was fatal to an adult.17a
Atropine does not protect against muscular weakness. The usual mechanism of death
appears to be respiratory failure. The use
of an oxygen tent or even the use of oxygen
under slight positive pressure is advisable
and should be started early. Watch the patient
constantly, since the need of artificial respiration may appear suddenly. Equipment for
oxygen therapy and for artificial respiration
should be placed at the patient's bedside in
readiness while the patient is on his way to
the hospital. Cyanosis should be prevented
by the most suitable means, since continued
anoxia aggravates the depression of the
respiratory center caused by the poison directly. Complete recovery may occur even after
many hours of artificial respiration have been
necessary.
If there is any reason to think that the
eyes may have been contaminated, irrigate
them with isotonic saline solution or water.
The absorption of some of the organic phosphorus insecticides by the eye is remarkably
rapid.
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The acute emergency lasts 24 to 48 hours,
and the patient must be watched continuously
during that time. Favorable response to one
or more doses of atropine does not guarantee
against sudden and fatal relapse. Medication
must be continued during the entire emergency. Any person who is ill enough to receive a single dose of atropine should remain
under medical observation for 24 hours, because the atropine may produce only a temporary relief of symptoms in what may prove
to be a serious case of poisoning. Atropine
should never be administered for preventive
purposes to persons who have not become
sick.
Miosis and headache may persist after recovery from poisoning by organic phosphorus
insecticides is otherwise largely complete. In
some cases, the systemic administration of
atropine is followed by partial or temporary
dilatation of the pupils. Miosis responds
more dependably to 2-PAM. If further
systemic treatment is not necessary, the miosis and associated headache will respond to
the instillation of 0.5% to 1% atropine solution or 0.5% atropine ointment into the eyes.
Following exposure heavy enough to produce symptoms, further organic phosphorus
insecticide exposure of any sort should be
avoided. The patient may remain susceptible
to relatively small exposures to the same or
any other organic phosphorus compound
until regeneration of cholinesterase is nearly
complete.
Prevention of Poisoning
The most important single factor in the
prevention of poisoning is a knowledge of
the hazards involved in handling the various
anticholinesterase compounds. It is essential
that the facts about the toxicity of these materials be learned through research and then
that these facts be made known to all concerned, including the formulating plant
worker, the commercial sprayman, the
farmer, the householder (who may purchase
these insecticides for use in his house or
garden and, if not adequately warned, may
leave the toxic materials accessible to children
or other irresponsible persons), and the
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physician who may be called upon to treat
pOlson mg.
In persons occupationally exposed, poisoning can best be prevented by constant,
thoughtful care and by use, where indicated,
of safety devices such as protective clothing,
respirators, masks, air-conditioned cabs, or
special factory ventilation.
Prevention can also be approached by observing trends in serial blood cholinesterase
determinations on persons constantly exposed. The interpretation of individual
values in asymptomatic persons is difficult.
It is clear, however, that a single very low
enzyme value for one worker or a low
average value for a group of exposed workers is an indication of the need for improved
personal care or better mechanical protection
or both. In a similar way, prevention of
poisoning may be helped by proper evaluation of the amount of urinary excretion of
biotransformation products.
Direct methods are also available to measure the exposure which spray operators have
to pesticides during their usual conditions of
work. 42
Severe poisoning may at times be prevented by the immediate recognition and correction of contamination. Prompt, effective
medical treatment may prevent a mild poisoning case from developing into a serious one.

Comment and Summary
Poisoning due to organic phosphorus compounds may be encountered in relation to
their use as insecticides; as chemical warfare
agents; or as drugs for the treatment of abdominal distention, glaucoma, or myasthenia
gravis. The principal, if not the only, pharmacologic action of the organic phosphorus
insecticides is inhibition of the enzyme
cholinesterase. The inactivity of this enzyme
results in an accumulation of unhydrolyzed
acetylcholine and the appearance of signs and
symptoms referable to overstimulation of the
parasympathetic nervous system. The drug
of choice in the treatment of organophosphorus poisoning has been atropine. Atropine
therapy produces relief of certain symptoms
Durham-Hayes
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based on blocking the action of excess acetylcholine, but it has no effect on the basic
biochemical pathology involved in anticholinesterase poisoning. With regard to symptoms,
atropine is effective in treating those effects
referable to the central and muscarinic action
of acetylcholine but has no effect on the nicotinic action.
More recently a series of antidotes has been
developed that are able to reverse the combination between the cholinf'sterase molecule
and the inhibitor. These compounds are
oximes and include salts of, for example, 2PAM (2-pyridine aldoxime methiodide) ,
DAM (diacetylmonoxime), MINA (monoisonitrosoacetone) and TMB-4 (I,l'-trimethylene bis ( 4-formyl-pyridinium bromide)
dioxime) . Since the oximes and atropine
have different sites of action in the mammalian body, it is preferable to use these 2
agents in combination and thus take advantage of the antidotal effects at both points.
The most widely used of the oximes in
treating poisoning is 2-PAM. This compound has at least 3 actions that may be of
importance in the treatment of poisoning by
an organic phosphorus compound. These
actions are: ( I) reactivation of inhibited
cholinesterase, (2) reaction with and inactivation of the organic phosphorus molecule,
and (3) inhibition of cholinesterase. Atropine has none of these actions. The dominant
effect of therapeutic doses of 2-P AM in
poisoned animals is reactivation of inhibited
cholinesterase. Application of 2-P AM reactivates inhibited cholinesterase both in vitro
and in vivo, except that it has little or no
effect on the enzyme in the brain. The nonquaternary oximes ( such as DAM and
MINA) are able to penetrate the blood-brain
barrier. With any given inhibitor and reactivator, the extent of reactivation of cholinesterase activity depends upon how long the
inhibitor and enzyme have been in contact.
Although the value of 2- PAM in the treatment of organic phosphorus poisoning was
discovered in the United States and procedures for its use were developed here, and
although this antidote is now widely available
for use by physicians in a number of other
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countries (England, Israel, Japan, and New
Zealand), it can be purchased in this country
only by qualified physicians for clinical investigational use. It is unfortunate that no
firm has seen fit to market 2-PAM commercially for prescription use in the United
States.
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HEALTH HAZARDS OF PESTICIDES

T

he pesticide-related problem t~at the average
physician is most likely to face and about
which he must take immediate and definitive action
is acute poisoning due to occupational or accidental
exposure or to suicidal ingestion.
Almost every pesticide can cause poisoning if it
is swallowed. For many years and at least as late
as 1959, the arsenicals caused more accidental
deaths than any other group of pesticides. This is
almost certainly due to the casualness with which
they are still stored and the ease with which they
can be found and ingested by children and other
uninformed people. The arsenical pesticides have
never been an important source of occupational
disease. Among the newer pesticides, greatest attention has focused on the chlorinated hydrocarbon
and the organic phosphorus insecticides. Although
the chlorinated hydrocarbons have caused a moderate number of cases of accidental posioning, their
record of occupational safety is generally good. In
fact, the great amount of study they continue to
receive is justified almost exclusively by their persistence as residues on treated crops and their relatively prolonged storage in the tissues of domestic
animals and man. However, careful regulation has
p.revented the residues from offering anything but a
potential problem. There is no confirmed record of
clinical effect from eating food treated with pesticides according to approved agricultural practice.
From the standpoint of occupational hazard, the
more toxic organic phosphorus insecticides are the
outstanding offenders among the newer agricultural
chemicals. This is true in spite of the strict regulation imposed on them from the beginning. This
regulation and the extensive educational campaign
that has accompanied their introduction and use
undoubtedly have restricted both occupational and
accidental poisoning by these compounds. Granted
that all noncriminal poisoning can be traced to
"carelessness," the growing importance of the more
toxic organic phosphorus insecticides as reported
causes of occupational disease 1 is almost certainly
due to the tremendous increase in their use, to their
inherent toxicity, and to the ease with which many
of them are absorbed through the skin.
Two factors specifically favor success in the treatment of poisoning with the organic phosphorus
compounds, i.e., the short duration of the emergency and the existence of effective antidotes. The
acute episode lasts only from 24 to 48 hours. Most
deaths occur within the first 24 hours, and if a patient survives this long, he usually recovers completely.
The principal pharmacologic action of the organic phosphorus insecticides, if not the only one, is

inhibition of the enzyme cholinesterase. This results
in an accumulation of unhydrolyzed acetylcholine
and. therefore, in signs and symptoms referrable to
over-stimulation of the parasympathetic nervous
system. The drug of choice in the treatment of organophosphorus poisoning has been atropine,
which relieves certain symptoms by pharmacologiC
blocking of the action of acetylcholine. Atropine,
however, has no effect on the basic, biochemical
pathology involved in anticholinesterase poisoning.
Furthermore, it has no effect on the nicotinic action
of acetylcholine although it is effective in treating
those symptoms referrable to the central and muscarinic actions of this neurohumor.
More recently a series of antidotes has been developed that can reverse the combination between
the cholinesterase molecule and the inhibitor.
These compounds are oximes. The outstanding
members of this group are the salts of 2-pyridine
aldoxime, including the methiodide (2-PAM iodide ), the methochloride (2-PAM chloride), and
the ethanesulfonate (P2S). 2-PAM chloride is sold
in the United States by the Campbell Pharmaceutical Company, Inc., 121 East 24th St., New York
City; under the trade name Protopam. This drug is
marketed under a limited license for sale to qualified physicians for clinical investigations only.
Emergency supplies are available at some poisoncontrol centers, at many medical schools, or from
the U.S. Public Health Service laboratories in Atlanta, Ga., Wenatchee, Wash., and Phoenix, Ariz.
In the July issue of the At-chives of Environmental Health (p. 21) there is a review by William F. Durham and Wayland J. Hayes, Jr., on the
therapy of organic phosphorus poisoning. Special
attention is given in this review to compounds that
reactivate inhibited choliJ;lesterase and to their
proper clinical use in combination with atropine.
Extensive animal research on salts of 2-pyridine
aldoxime has been completed. Well-documented,
clinical use of these compounds in more than 40
cases of parathion poisoning has established their
effectiveness and safety for this purpose. More limited experience indicates their value in the treatment of poisoning by some other organic phosphorus compounds.
Detailed information on the clinical use of these
drugs is now available to physicians through the
above-mentioned review. For maximum usage to
be made of the considerable knowledge now available on treatment of anticholinesterase poisoning, it
is necessary that one of these oxime salts be made
generally available for prescription by physicians in
the United States.
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